VANTEX CENTRAL VENOUS CATHETER WITH OLIGON MATERIAL WITH OR WITHOUT AMC THROMBOSHIELD COATING

Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

BAXTER HEALTHCARE CORP.

The following data is part of a premarket notification filed by Baxter Healthcare Corp. with the FDA for Vantex Central Venous Catheter With Oligon Material With Or Without Amc Thromboshield Coating.

Pre-market Notification Details

Device IDK992532
510k NumberK992532
Device Name:VANTEX CENTRAL VENOUS CATHETER WITH OLIGON MATERIAL WITH OR WITHOUT AMC THROMBOSHIELD COATING
ClassificationCatheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Applicant BAXTER HEALTHCARE CORP. 17221 RED HILL AVE. PO BOX 11150 Irvine,  CA  92614 -5627
ContactJason Smith
CorrespondentJason Smith
BAXTER HEALTHCARE CORP. 17221 RED HILL AVE. PO BOX 11150 Irvine,  CA  92614 -5627
Product CodeFOZ  
CFR Regulation Number880.5200 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-07-29
Decision Date2000-06-13
Summary:summary

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.